HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED revenue for the last year amounted to 1.29 B EUR, the most of which — 790.72 M EUR — came from its highest performing source at the moment, Oncology, the year earlier bringing 768.05 M EUR. The greatest contribution to the revenue figure was made by China — last year it brought HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED 1.30 B EUR, and the year before that — 1.30 B EUR.